Correction to: Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Additional Benefit.

Correction to: Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Additional Benefit.

Publication date: Aug 02, 2020

During the proofing process, the misspelling of “additional” occurred while changing the title of the article. The complete title should be “Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Additional Benefit”.

Concepts Keywords
Coronavirus disease
Functional groups
Remdesivir
Nucleotides
Nitriles
COVID-19
Chemistry
Antivirals
Organic compounds

Original Article